Compugen (CGEN) Interest Expenses (2011 - 2025)
Compugen (CGEN) posted quarterly Interest Expenses of $796000.0 for Q4 2025, down 99.28% year-over-year from $109.8 million in Q4 2024, and down 36.98% on a QoQ basis from $1.3 million in Q2 2025.
Compugen (CGEN) Interest Expenses (2011 - 2025) Analysis & Trends
Compugen has reported Interest Expenses for 15 years, with the latest figure at $796000.0 in Q4 2025.
- Interest Expenses for Q4 2025 came in at $796000.0, down 99.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $796000.0 (down 99.28% YoY), and the FY2025 annual result was $55.7 million, down 49.31% from the prior year.
- Interest Expenses declined to $796000.0 in Q4 2025, from $1.3 million in the prior quarter.
- Over five years, Interest Expenses peaked at $109.8 million in Q4 2024 and troughed at $796000.0 in Q4 2025.
- A 5-year average of $32.2 million and a median of $1.9 million in 2023 frame the typical range for Interest Expenses.
- The widest annual swing landed in 2024, when Interest Expenses soared 5643.41%; it then plunged 99.28% in 2025.
- A 5-year view of Interest Expenses shows it stood at $3.3 million in 2021, then jumped by 3118.21% to $106.9 million in 2022, then tumbled by 98.21% to $1.9 million in 2023, then soared by 5643.41% to $109.8 million in 2024, then plunged by 99.28% to $796000.0 in 2025.
- Per Business Quant data, the three most recent Interest Expenses figures were $796000.0 in Q4 2025, $1.3 million in Q2 2025, and $109.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.67 Mn |
| Dec 31, 2025 | 55.67 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Dec 31, 2024 | 109.81 Mn |
| Dec 31, 2024 | 109.81 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Dec 31, 2023 | 108.07 Mn |
| Dec 31, 2023 | 108.07 Mn |
| Dec 31, 2022 | 106.94 Mn |
| Dec 31, 2022 | 106.94 Mn |
| Dec 31, 2021 | 98.76 Mn |
| Dec 31, 2021 | 98.76 Mn |
| Dec 31, 2020 | 91.62 Mn |
| Dec 31, 2020 | 91.62 Mn |
| Dec 31, 2019 | 75.59 Mn |
| Dec 31, 2019 | 75.59 Mn |
| Jun 30, 2019 | 1.41 Mn |
| Jun 30, 2019 | 1.41 Mn |